-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Keyuan Pharmaceutical shines at CPHI Milan 2024, adding new momentum to its global journey!
Publish Time:
2024-10-11
From October 8 to 10, CPHI Milan 2024—the global pharmaceutical industry’s premier event—officially kicked off with great fanfare in Milan, Italy. As one of the most influential trade shows in the global pharmaceutical sector, this year’s exhibition brought together pharmaceutical raw material suppliers, manufacturers, R&D institutions, and industry professionals from around the world, fostering discussions on emerging trends, pressing challenges, and promising opportunities shaping the future of the pharmaceutical industry.
From October 8 to 10, CPHI Milan 2024—the global pharmaceutical industry's premier event—bustled with excitement as it kicked off in Milan, Italy. As one of the most influential trade shows in the global pharmaceutical sector, this year's exhibition brought together pharmaceutical raw material suppliers, manufacturers, R&D institutions, and industry professionals from around the world, fostering discussions on emerging trends, pressing challenges, and promising opportunities shaping the future of the pharmaceutical industry.
As a leading enterprise in China’s niche segment of chemical APIs, Keyuan Pharmaceutical (stock code: 301281.SZ) was invited to participate in this prestigious event, showcasing its outstanding R&D capabilities and forward-looking international expansion strategy to the global audience.
Since its establishment in 2004, Keyuan Pharmaceutical has been steadfastly committed to advancing the pharmaceutical and healthcare industry. After two decades of focused and meticulous development, the company has built strong competitive advantages in key therapeutic areas such as diabetes, anesthesia, cardiovascular diseases, and mental health conditions. All of its products have earned national GMP certification, while its core offerings proudly hold the EU CEP certificate. Moreover, Keyuan Pharmaceutical has successfully navigated official regulatory approvals from multiple countries, including the U.S. FDA, Japan’s PMDA, and South Korea’s MFDS, firmly positioning itself on the path toward global expansion and sustained growth.
At the CPHI Milan 2024 exhibition, Keyuan Pharmaceutical's booth captivated both new and existing customers with its cohesive color scheme of tech-inspired blue and medical-grade white, drawing them in for closer looks and inquiries. The core products on display not only highlighted the company's deep-rooted expertise in the pharmaceutical industry but also underscored its exceptional strength in technological innovation and quality assurance.
During the exhibition, Keway Pharmaceutical's international marketing team engaged in in-depth discussions and product exchanges with partners from around the world, strengthening strategic collaborations with existing customers while also attracting more potential clients. This has further propelled the company’s comprehensive development across R&D, manufacturing, and sales, enhancing its global influence and competitiveness in the pharmaceutical market, and driving new successes in the implementation of its internationalization strategy.
As the exhibition drew to a close, Keyuan Pharmaceutical embarked on its journey home, brimming with收获 and hope. Yet this overseas pharmaceutical journey was far from over—it marked only a new starting point in Keyuan’s global expansion.
Keyuan Pharmaceutical will take this exhibition as an opportunity to deepen its engagement in the pharmaceutical industry, strengthen lean manufacturing, and solidify its competitive edge. With unwavering determination and a fresh, proactive approach, the company will actively explore overseas markets, continuously enhance communication and collaboration with international partners, and drive performance toward new breakthroughs.
Latest News
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline